A non-invasive screening solution for early detection of diabetes. This product enables healthcare providers to identify at-risk patients without the need for invasive procedures.
Manufactured by
China
Shenzhen Create Medical Technology Co., Ltd. manufactures breath diagnostic devices for detecting conditions including H. pylori infection (13C/14C breath tests), gastrointestinal disorders (hydrogen/methane analyzers), airway inflammation (NO analyzers), and halitosis (VSC analyzers). The company also produces non-invasive diabetes screening equipment using AGE detection technology and AI-assisted medical examination systems. Products are exported to over 20 countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
Biomerica, Inc.
United States · 3 relevant products
KANROTA
China · 2 relevant products
Wuxi BioHermes Bio & Medical Technology Co., Ltd.
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Beijing Laxons Technology Co., Ltd.
China · 2 relevant products
Polaris Diagnostics Europe UG
Germany · 2 relevant products
HVD Vertriebs GmbH
Austria · 2 relevant products
Camtech Diagnostics Pte Ltd
Singapore · 1 relevant product
Optain Health
Australia · 1 relevant product
45 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 71 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
Biomarker-based diagnostic test for early detection and screening of diabetes mellitus. This test supports the company's focus on early identification and intervention in metabolic diseases. The product is part of comprehensive chronic disease screening offerings.
Biomerica, Inc. · United States
A diagnostic test for screening diabetes in at-home and clinical laboratory settings. Supports early detection of this high-prevalence chronic medical condition.
KANROTA · China
Non-invasive electrical conductivity measurement device for early diabetes risk assessment and complication evaluation. Assesses autonomic nervous system balance through distal nerve endings evaluation. Suitable for preventive screening programs.
Wuxi BioHermes Bio & Medical Technology Co., Ltd. · China
Comprehensive diabetes screening using multiple biomarkers including fasting blood glucose, 2-hour oral glucose tolerance test results, and glycated hemoglobin levels. Enables early detection and stratification of diabetes risk in high-risk populations.
Anbio Biotechnology Limited · Germany
Metabolic testing suite measuring glucose, HbA1c, and related biomarkers for diabetes assessment. Enables risk stratification and disease monitoring.
Beijing Laxons Technology Co., Ltd. · China
A comprehensive screening system combining quantitative sensory testing, vibration threshold measurement, and infrared assessment for early detection of diabetic foot complications. The kit enables efficient identification of neuropathy and vascular insufficiency risk in diabetic patients.
Polaris Diagnostics Europe UG · Germany
Comprehensive preventive health screening system measuring essential biomarkers for early risk identification. Supports proactive health management across dental, cosmetic, and longevity medicine.
HVD Vertriebs GmbH · Austria
Precision medicine screening platform for early detection of genetic and metabolic disorders in newborns.
Camtech Diagnostics Pte Ltd · Singapore
Self-sampling colon cancer screening test designed for point-of-care diagnostics. This non-invasive testing solution enables early detection of colorectal cancer through convenient at-home sample collection, supporting mass screening programs and clinical diagnostic workflows.
Optain Health · Australia
Non-invasive screening system utilizing AI algorithms to detect referable retinal diseases and chronic conditions from fundus images. The system generates comprehensive health risk reports for population screening and disease risk stratification.
Polaris Diagnostics Europe UG · Germany
Rapid assessment panel for early disease risk detection including vitamin D, CRP, and metabolic markers. Enables proactive health counseling and preventive intervention.
Chengdu Stork Healthcare Co.,Ltd. · China
Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.
59 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products